Disease modifying therapies in multiple sclerosis

被引：2
|
作者：
Khatri, BO
McQuillen, MP
机构：
来源：
NEUROLOGY | 2002年 / 59卷 / 03期
关键词：
D O I：
10.1212/WNL.59.3.471
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：471 / 472
页数：2
相关论文
共 50 条
  • [21] New and emerging disease modifying therapies for multiple sclerosis
    Saidha, Shiv
    Eckstein, Christopher
    Calabresi, Peter A.
    YEAR IN IMMUNOLOGY, 2012, 1247 : 117 - 137
  • [22] Patient education on disease modifying therapies in multiple sclerosis
    Chrysovitsanou, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 136 - 136
  • [23] Using disease-modifying therapies for multiple sclerosis
    不详
    JOURNAL OF ADVANCED NURSING, 2004, 48 (03) : 314 - 314
  • [24] Emerging multiple sclerosis disease-modifying therapies
    Giacomini, Paul S.
    Darlington, Peter J.
    Bar-Or, Amit
    CURRENT OPINION IN NEUROLOGY, 2009, 22 (03) : 226 - 232
  • [25] Emerging Disease-Modifying Therapies in Multiple Sclerosis
    Perumal, Jai
    Khan, Omar
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2012, 14 (03) : 256 - 263
  • [26] Cost of disease-modifying therapies for multiple sclerosis
    Brown, Murray G.
    NEUROLOGY, 2015, 84 (21) : E181 - E185
  • [27] DISEASE-MODIFYING THERAPIES FOR MULTIPLE-SCLEROSIS
    CARTER, JL
    CNS DRUGS, 1995, 3 (02) : 99 - 114
  • [28] Safety of Newer Disease Modifying Therapies in Multiple Sclerosis
    Jalkh, Georges
    Abi Nahed, Rachelle
    Macaron, Gabrielle
    Rensel, Mary
    VACCINES, 2021, 9 (01) : 1 - 30
  • [29] Benign multiple sclerosis in the era of disease modifying therapies
    Diaz-Cruz, Camilo
    Gonzalez, Cindy
    Chua, Alicia
    Healy, Brian
    Sattarnezhad, Neda
    Stankiewicz, James
    Severson, Christopher
    Bhattacharyya, Shamik
    Kimbrough, Dorian
    Glanz, Bonnie
    Weiner, Howard
    Chitnis, Tanuja
    NEUROLOGY, 2017, 88
  • [30] Economics of Multiple Sclerosis Disease-Modifying Therapies in the USA
    Daniel M. Hartung
    Current Neurology and Neuroscience Reports, 2021, 21
12345